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Implications of New Data on Lead Toxicity for
Managing and Preventing Exposure
by Ellen K. Silbergeld*
Recent advances in research on low-level lead poisoning point to the need to increase efforts to prevent ex-
posure. Currentbiomedical consensus accepts thatblood lead levels as low as 5 to 15 mcg/dL are riskyto fetuses,
youngchildren, andadults. Lead at low dose is associated with increasedblood pressure in adults, andchronic
exposure has been associated in cohort studies with kidney disease and cancer. Data on lead toxicokinetics
also points to the hazards oflow-level, chronic exposure, since the lead that is accumulated over time in bone
can be released at arelatively rapid rate during pregnancy and menopause. Sources that contribute to current
lead exposure of the general population include unabated lead-based paint and contaminated soils, as well
as lower level but pervasive sources in drinking water, food, and consumer products.
Recent information on the nature and extent oflead tox-
icity has presented a challenge for preventing disease that
continues to exceed our ability to formulate effective public
health and environmental policy. It can be claimed that of
the major environmental factors in human disease, more has
been done worldwide to reduce sources of lead exposure
than for any other single toxicant. Although overall the net
usage of lead has not substantially declined in the world
economy, some of the more dispersive and more directly
available sources of lead in the general environment have
been controlled in several countries to an extent, through
such major actions as reducing the allowable concentrations
of lead in paint, automotive fuels, and certain canning and
printing materials. These control measures have been asso-
ciated with subsequent reductions in median blood lead
levels, as demonstrated in surveys conducted in the U.S.,
U.K., and other countries (1-3).
However, at the same time, in general, the overall preva-
lence oflead toxicity has not been reduced. There are two
reasons forthis continuingfailure in management and preven-
tion: first, the lack of effective action to remediate known
sources oflead in the environment; and second, the impact
of new biomedical data on the definition oflead toxicity. With
respect to the first issue, in most cases, the high-impact
sources of lead, such as lead in old paint found in housing
stock in the U.S. and to a lesser extent in other countries,
and lead contamination ofsoils in the vicinity ofprimary and
secondary smelters around the world have yet to be effec-
tively cleaned up. The magnitude ofthese two sources, in
terms of estimated population impact, is shown in Tables
1 and 2 (4).
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Table 1. Estimates on numbers of children under 7 years exposed
to lead-based paint (LBP).a
Age of housing
Pre-1940
1940-1959
1960-1974b
Total
Number of
houses
with LBP
20,505,000
16,141,000
5,318,000
41,964,000
Unsound
housing
units
964,000
758,000
250,000
1,972,000
Number of
children in
LBP houses
5,885,000
4,632,000
1,526,000
12,043,000
Number in
unsound
housing
277,000
218,000
72,000
567,000
aData from ATSDR (4).
bLead-based paint was banned from residential use in 1973. Nevertheless,
some houses constructed or painted after that time may have LBP.
Table 2. Estimates of numbers of children under 7 years exposed
to lead from primary and secondary lead smelters in the U.S.a
Source Number Numbers of children exposed
Primary smelter 5 21,000
Secondary smelter 23 187,000
Total 208,000
aData from ATSDR (4). These data referonly to operatingsmelters. Addi-
tional populations live near closed facilities with high levels ofenvironmental
contamination.
Methods forthe safe and effective abatementoflead-based
paint in houses have yet to be developed andvalidated (5,6).
A pilot-scale project in the U.S. is addressing the methods
necessary to evaluate and abate sites with high concentra-
tions oflead in surface dusts and soils (7), which were iden-
tified as a hazard over a decade ago (8,9). In some instances,
levels oflead in surface soils in residential areas are extra-
ordinarily high: in a small survey of backyards on Staten
Island downwind from a secondary lead smelter in Cartaret,
NewJersey, concentrations oflead between 1000 and 4000
ppm were found (10). Anunpublished survey conducted forE. K. SILBERGELD
the New York City Department of Planning reported that
levels oflead in street dust were frequently above 2000 ppm,
with an arithmetic mean of 5777 ppm (11). The unsolved
problems of managing both industrial and municipal wastes
present continuing inputs of lead; for example, the shift
toward incineration ofprocessing municipal solid waste has
the potential to generate tons of lead in ash residues (12).
Ofparticular relevance to evaluating the advances in lead
research that have taken place since 1979, there has been
a substantial revision in consensus opinion as to the levels
oflead exposure that are associated with damage to human
health. As pointed out by Needleman (13), over the past
50 years in medicine, this evaluation of exposure and risk
has changed radically, from an opinion held through the 1950s
that blood lead levels as high as 80 mcg/dL were not risky
to health to the current opinion that blood lead levels as
low as 10 mcg/dL may be hazardous to children and the fetus
(14). As shown in Figure 1, this revision in defining lead tox-
icity is alone responsible forincreasing by a factor of 10 the
estimated prevalence of medically unacceptable levels of
exposure to lead in the U.S. population. [See "The Nature
and Extent of Lead Poisoning in Children in the U.S." (4)
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FIGURE 1. Distribution ofblood lead levels in the U.S. population, based upon
data in Annest et al. (1). These data were collected from 1976 to 1980;
blood lead levels inthe U.S. population in 1988 are estimated to be somewhat
lower (4), but a similar distribution probably holds.
for a complete discussion on the prevalence oflead exposure
in the U.S.].
In addition, newer information on the adverse health
effects oflead has broadened the scope of concern beyond
the child to include other members ofthe population. Since
the pioneering work ofBlackfan and McKhann in the early
years of the century, environmental lead toxicity has been
generally considered a pediatric disease (15-17). However,
lead is known to affect adults, and occupational lead toxicity
remains a major problem in industry throughout the world
(18-20). Some recent studies have reported associations
between relatively low levels ofchronic lead exposure and
increased blood pressure (21). Increases inblood pressure
have been found inpopulations whose blood lead levels were
as low as 12 mcg/dL; an analysis ofthe NHANES II data set
could not define a threshold for this effect in men. In an
Australian population exposed to environmental lead in soils,
dusts, drinldng water, and air, an increased risk of spon-
taneous abortion was found in women whose blood lead
levels were only slightly increased above control levels (22).
Spontaneous abortion is likely to reflect actions of lead on
both fetus and mother (23). In a group of men with kidney
failure, higher levels oflead in bone were found than in age-
matched controls, suggesting a correlation with earlier
chronic, low-level lead exposure (24). Cohort studies con-
ducted on occupationally exposed persons in the U.S. and
Sweden have reported increased incidence of cancer in lead
workers (25-28); while these exposures were likely to have
been heavy during employment, as compared to general
environmental exposures of the present time, particularly
in older cohorts whose work experience took place before
regulation of working conditions in the lead trades, the
mechanisms and dose response for lead-induced cancer is
unknown.
Finally, new data on the mobilization oflead stored in bone
may alter estimations of the long-term risks of very low-
level chronic exposure. Over 95% of the lead that is ab-
sorbed and retained is stored in bone (29,30). Because the
turnover ofthis pool is very slow, on the order of decades
(29,31), over time bone accumulates considerable concen-
trations oflead even in the absence ofunusual or peak ex-
posures. This compartment is not static, however, and fac-
tors that influence bone cell function and status appear to
affect lead retention. As shown in Table 3, we have found
a significant release oflead stored inbone during menopause
Table 3. Effect of menopause and prior pregnancy on blood and plasma lead levels in women.a
All women White Black
mcg/dL % Change mcg/dL % Change mcg/dL % Change
Change in blood lead
Pre/postmenopause 1.47 12.6 1.67 14.7 0.62 4.6
Pre/postmenopause
Never pregnant 2.56 22.0 2.67 23.4 1.31 9.8
Ever pregnant 1.37 11.8 1.45 12.7 0.50 3.7
Change in plasma lead
Pre/postmenopause 0.136 16.2 0.150 18.3 0.030 3.0
Pre/postmenopause
Never pregnant 0.347 41.3 0.386 47.2 0.104 10.3
Ever pregnant 0.113 13.4 0.125 15.3 0.015 1.5
aFrom Silbergeld et al. (32).
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and pregnancy (32). Mobilization of bone lead during
pregnancy (and also probably lactation, as reported in ex-
perimental studies) may combine with ongoing maternal ex-
posures to increase the total dose presented to the fetus
and neonate (33).
Mobilization of bone lead during bone demineraiization
states raises questions as to the potential toxic effects of
lead in aging populations and other groups at risk for
demineraiizing diseases, such as kidney dialysis patients and
other conditions of osteopenia or osteomalacia induced by
dietary deficiency ordisease. Withthe shiftindemographics
in the U.S. and western Europe toward an increase in
numbers ofpersons over 70, the health ofthis agingpopula-
tionbecomes ofgreater concern (34). Itis important tobegin
investigations ofthe potential effects oflead on this group.
New concern over low-level lead toxicity will guide deci-
sions as to methods for reducing overall exposures to lead
in order to prevent disease. Inthe absence ofeffective treat-
ment for lead toxicity, prevention of exposure remains the
appropriate method forpreventing disease (13,35). In addi-
tion to developing andimplementing effective abatement of
existing lead sources, particularly those that present high
risks to specific populations, reconsideration of continuing
uses oflead must be undertaken in light of their contribu-
tion to overall exposure.
Three examples mayillustrate this. Inthe U.S. since 1983,
a major reduction in the use of lead in gasoline has been
achieved through regulation by the EPA. However, in the
third quarter of 1988, 430 miilion g of lead were used in
gasoline in the U.S. (Around the world, the use of lead in
gasoline is still increasing, due to lack ofregulation on lead
additives in many of the countries where the number and
use ofautomobile vehicles is increasing the fastest.) Some
ofthat leaded gasoline is used in farm vehicles, which con-
tinue to enjoy an exemption from regulations imposed on
other vehicles. Lead emissions from farm vehicles, while
a small fraction of the total vehicle miles in the U.S., may
contribute to general lead exposures through contamination
of the food supply. We have examined data from the U.S.
Food and DrugAdministration (FDA) and found thatin foods
which grow naturally exposed to ambient air (such as
apples, tomatoes, and beans), concentrations of lead are
approximately four times those in naturally covered foods
(such as corn and peas) (36). These concentrations are
relatively low, but in the context of a revised evaluation of
the hazards oflead toxicity, it is useful to identify all poten-
tially controllable sources of lead exposure.
Another source oflead exposure that has escaped much
notice and control untilrecently has been the release oflead
from plumbing into drinking water. Possibly because of in-
creasing acidity ofsurface waters due to atmospheric pollu-
tion sources and because of the overall aging of the water
distribution infrastructure, lead concentrations in drinking
waterinthe U.S. are relativelyhigh. EPAhas estimated that
42 millionAmericans are currentlyexposed to dring water
in excess of 20 ppb. Patterns of water use tend to weight
the importance ofthis source, since water lead concentra-
tions increase as a function oftime ofcontact ofaggressive
water Oow pH andlow mineralcontent) withlead-containing
Table 4. Lead levels in drinking water in Philadelphia (1987):
first draw and fully-flushed samples.a
Test results
Residence
Residence
Residence
Residence
Sheraton Society Hill
Residence
Residence
Schmidt's Brewery
Bright Star Child Care
Residence
The Piers at Penn's Landing
Police SOD building
The Chocolate Factory
Philadelphia Protestant House
and Romper Room Family Concept
The Chart House
Residence
YWHA
Residence
Delran Builders
Residence
Residence
Curtis building
EPA Regional Offices
aTesting done by Water Test Corporation, NH.
Standing/flush, ppb
464/045
353/021
174/009
056/005
032/078
041/048
050/050
028/005
047/005
079/014
1294/066
119/106
1186/399
077/005
216/129
012/005
5067/087
043/005
226/045
075/005
733/614
043/012
162/165
plumbing. Thus, first-draw use or intermittent use, whicn
often occurs in the morning and at schools, tends to have
relatively higher concentrations oflead, sometimes as much
as 10 times the concentration offully flushed water (Table
4). Based on some of the data in Table 4, if a child con-
sumed only 500 mL of such water per day, this exposure
alone would exceed recommended dietary intake for lead.
Similarly, it is important to re-evaluate current uses of
lead in solders, glass, plastics, and pigments. These lead
sources occur in many consumer products. Although dur-
ingconsumeruse itis unusualforlead to become bioavailable
(with rare exceptions, such as the unfortunate use oflead-
based paints on decorative drinking glasses distributed as
promotionalitems recently in the U.S.), it is during disposal
that these lead-bearingitems canrelease leadinto the envi-
ronment. A recent EPA report calculated that almost 50,000
short tons oflead are discarded in municipal waste each year
(excludinglead-acid storage batteries). Many ofthese uses
are potentially substitutable. Since lead does not biodegrade,
disposal of lead-containing items will inevitably result in
releases oflead from the product matrix: plastic, paper, or
other materials. Some types of waste processing can ac-
celerate this process. High temperature incineration, which
is increasingly employed in waste management around the
world, mimics secondary smelting in causing the selective
enrichment ofresidues in lead and other metals, which are
indestructible byincineration. Moreover, modern incinerators
tend to yield residues composed ofsmall diameter ash par-
ticles, which are more easily transported throughout the
environment by wind and water and more readily incorpo-
rated into biota, including humans, by ingestion and inhala-
tion, than the lead in its original form in products. Concen-
trations of lead in ash and in distilled water leachate from
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Table 5. Concentrations of lead in municipal solid waste
incineration ash (12).
Total, Short-term Long-term
Fly ash ppm leachablea leachablea
Bottom ashb 1950 12 ppm Not done
Fly ash
Fabric filter 7055 75% 95%
Dry scrubber 3792 56% 80%
Wet-dry scrubber 1919 25% 63%
aConcentration or percent extracted into distilled water by standard tests
designed to predict short orlong-tern interactions ofpercolate throughlandflls.
bAverage of samples collected by Silbergeld at Heimdal, Norway, and
Jersey (Channel Islands).
ash are very high, as reported in measurements made on
the residues from operating incinerators, as shown in Table
5 (12).
In addition to health effects information, efforts at identi-
fying and preventing lead toxicity must be based on new
information on lead toxicokinetics. The distribution and reten-
tion oflead reflect the fact that almost all environmental expo-
sures are chronic rather than acute. Initial distribution may
reflect the rate of delivery of blood to various organs, but
the major factors governing long-term distribution of lead
are specific lead binding and transport proteins (37), cellular
sites with high affinity for lead, such as ATP (38), and hor-
monal and other regulatory factors related to essential
mineral metabolism (32). Under conditions ofrelatively con-
tinuous exposure over long periods ofthe life span, a near
steady state may be achieved with predictable distribution
oflead among body compartments (31). However, this dis-
tnrbution can be altered eitherbylarge fluctuations inexternal
lead exposure or by physiological changes that influence the
stability oflead storage sites, such as bone. There is substan-
tial redistribution oflead even within bone over the lifespan,
reflecting changes in bone physiology coincident with growth
and senescence (39). We know that lead metabolism dif-
fers greatly between children and adults, withyoungchildren
estimated to retain about 30 times the ingested dose oflead
as adults (3), but we know little about metabolic variations
among different subsets ofadults and children: forinstance,
pregnant women, calcium-deficient children, the aged, or
those with demineralizing diseases.
Lead is excreted into breastmilk during lactation (40,41).
The kinetics of lead excretion are not understood, and
nothing is known of nutritional or other factors that might
modulate the rate or amount oftransfer oflead from mother
to nursinginfant. One study found that women over30 years
ofage have higherlevels ofleadinbreastmilk thanto younger
women (42), which may reflect the greater concentrations
oflead in mineralized tissue as a function ofage, since bone
serves as a reservoir for calcium during lactation.
The need to estimate lead exposure over longer time
periods than 1 or 2 months and increased concern over the
potential release oflong-term stores of lead both focus at-
tention on developing new methods to determine body
burdens oflead. Because mineralized tissues represent the
compartment with the longest temporal integration term,
this is the ideal compartment for exposure assessment. At
present, methods for determining bone stores of lead are
under development. In occupational cohorts, with long-term,
relatively high exposures, in vivo measurement of lead in
bone by X-ray induced fluorescence techniques has been
shown to be useful (43). For pediatric populations, or per-
sons with relatively lower chronic exposures, it is not yet
clear that current methods have sufficient sensitivity under
conditions that meet criteria of radiological safety.
Biological markers that reflect longerterm exposure than
erythrocyte protoporphyrin (EP) or levels of lead in com-
partments other than blood may provide indicators ofexpo-
sure that predict risk more accurately than only measuring
lead in blood. Blood is the compartment in which both lead
and porphyrin markers are most commonly measured as
markers ofexposure; however, these markers only indicate
relatively recent exposures. Since the target organs ofcon--
cern for lead include the brain, heart, andkidney, it is rational
to consider biological signals of organ function that are
derived from these tissues. Unfortunately, the brain is-
relatively inaccessible, and it is difficult to discern from
peripherally available markers the status ofthe central ner-
vous system. No work has been done onbiological markers
of cardiovascular function that might indicate lead-induced
effects. For the kidney, it may be that recently identified
lead-binding proteins of renal origin may reflect exposures
of that organ and signal increased uptake and potential
damage (36,44).
Acritical need in this area is to develop methods to assess
lead exposure and predict outcome for fetuses exposed to
lead. For reasons noted above, monitoring maternal blood
lead may not completely predict fetal exposures or risk of
lead-associated effects on growth and development. Monitor-
ing pregnant women is constrained by particular concerns
to protect health; thus, X-ray analysis ofbone during preg-
nancy may be even more difficult to do than at other times
or in other populations. Work is needed to identify markers
ofembryofetal status during intrauterine development that
signal increased exposure to lead. Monitoring bone status
during pregnancy may be useful as an indicator ofpotential
mobilization of maternal lead stores.
Research on markers is also needed because ofthe rela-
tive insensitivity ofEP to increases in lead exposure at the
low end ofthe range. Detectable increases in EP are found
when blood lead levels exceed 25 mcg/dL (45); however,
recent health data establish a range of concern as low as
5 to 10 mcg/dL. Measuring these concentrations oflead in
blood is also difficult; external contamination becomes a great
problem, and the recommended method for sample collec-
tion is by venipuncture. Demands of quality control and
quality assurance also increase.
Thus, in conclusion, the newer data on the health effects
oflead enlarge the scope of public health concern for lead
toxicity in three ways: first, the levels oflead exposure that
are associated with demonstrably adverse effects are
significantly lower than the currentpediatric guidance level
of25 mcg/dL and the OSHA biomonitoring standard of 40
mcg/dL for adults; second, the populations potentially at risk
for low-level lead toxicity has been expanded beyond the
young child to include the fetus, adults, and the aging; and
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third, the toxicokinetics oflead points to the significant role
oflead stored in mineralized tissue as a contributing source
ofinternal lead dose under certain physiological conditions
that may coincide with periods oftarget vulnerability. These
findings serve to refocus concern over the need to remediate
existing high-level sources oflead in the environment, such
as dilapidated housing and contaminated soils, and to con-
trol ongoing sources that have been considered ofrelatively
minor importance, such as the continued use of lead addi-
tives in fuels and the widespread uses oflead in consumer
products. Although the past decade has seen substantial suc-
cess in controlling certain lead sources, the advances in our
knowledge of lead toxicity have outstripped our ability to
identify and control lead exposure overall. The only way out
ofthe treadmill is to develop an integrated public health and
environmental policy based upon a goal of reducing lead in
all persons below 10 mcg/dL by substantially reducing all
controllable sources of lead.
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